Two part lecture - 'Skin Cancer - Can we refer?' and 'Suspicious Lesions' (SW15-11-10-1)

AvailabilityCourse has taken place
Documents
Programme

Need help viewing PDF documents?

SubjectOral and maxillofacial surgery
DescriptionHead and neck malignancies are the worst prospect that any dental patient can face, and morbidity and mortality are still closely linked to how soon the diagnosis is made. The importance of early diagnosis for the patient has led the GDC to make oral cancer a recommended CPD subject. Also, because dentists are in a unique position of seeing patients regularly for examination, the diagnosis and referral of skin lesions is becoming increasingly relevant. In these lecture Mark Singh will update the dental team on the diagnosis, referral, and contemporary management of malignant and premalignant lesions and conditions and lesions that affect the skin and oral cavity.
Additional information

This meeting is run jointly between the Bristol BDA and Dept of Postgraduate Dental Education - Health Education South West

REGISTRATION IS FROM 6PM, WITH THE ACTUAL LECTURE STARTING AT 6.30PM.

VenueFuture Inn Hotel, Bristol - Bristol & N Somerset  View details
Date & timeTuesday 10 November 2015, 18:00 to 22:00
LecturerMr Mark Singh  View details
Target audience

Recommended to all

Development outcomeNo development outcome
Course styleLecture
Catering Meal
Core topic Not a core topic
CPD hours2:30
Cost£40.00
Aims

To provide an overview of skin lesions relevant to the general dental practitioner and to update the general dental practitioner on the diagnosis, referral and management of malignant and premalignant oral lesions.

Objectives

By the end of the symposium delegates will:

  • Be aware of the different types of skin cancer and its increasing incidence
  • Be able to identify the three most common types of skin cancer
  • Be confident to refer skin lesions
  • Be aware of different treatment modalities for skin cancer
  • Be able to differentiate between benign and malignant lesions in the mouth
  • Be confident in assessing the urgency of referral
  • Be aware of the emerging therapies to reduce morbidity